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The spatial distribution of trace elements in human lymph nodes partially infiltrated by melanoma cells 
was determined by elemental bio-imaging. Imaging of 31P within the nodal capsule and normal lymph 
node tissue showed a clear demarcation of the tumour boundary, with a significant decrease in relative 
31P concentration within the tumour.  The location of the tumour boundary was confirmed by 
haematoxylin and eosin staining of serial sections and observation by light microscopy.  Further 
enhancement of the tumour boundary was achieved by imaging the 31P/34S ratio.  31P/66Zn ratio images 





Melanoma is a malignant tumour that arises from melanocytes that are normally found in the basal cell 
layer of the epidermis of the skin.  The WHO estimated the global mortality from melanoma in 2000 at 
over 65,0001.  9,722 new cases of melanoma were diagnosed in Australia in 2004, with 1,200 reported 
fatalities2 giving Australia the highest incidence of melanoma in the world.  It has been suggested that 
global incidence rates of melanoma will double every 10-20 years for the foreseeable future3. 
 
Mortality from most solid malignancies usually occurs as a consequence of tumour metastasising from 
its site of origin to distant locations. Lymph nodes receive lymphatic fluid directly from the primary 
tumour and are the most common first sites to harbour metastases. Metastatic melanoma is present in 
lymph nodes in approximately 20% of melanoma patients with primary tumours >1mm in thickness4 .  
Identification of the presence of melanoma metastases in clinically negative regional lymph nodes is 
usually achieved by surgical removal of the lymph node most likely to harbour metastases (i.e. the 
sentinel lymph node) and laborious histopathological examination of tissue sections stained both with 
hematoxylin and eosin (H&E) and immunohistochemically for various melanoma-associated antigens. 
The tumour-harbouring status of the sentinel lymph node is the most important prognostic factor in 
patient’s presenting with early stage melanoma5. 
 
An alternative method for detection of melanoma in lymph nodes is chemical imaging. Fourier 
transform infrared (FTIR) spectral imaging has been used to investigate cutaneous melanomas6, 7. 
Recently, K-means clustering was used to identify infrared spectral similarities in skin basal cell 
carcinomas (BCCs), highlighting the utility of imaging technology and chemometrics for the diagnosis 
of cutaneous malignancies8.   
 
Although trace elements have long been associated with malignancy, their role and prevalence in 
melanoma is unknown.  Phosphorus/sulphur ratios have been shown to be higher in malignant human 
hepatocarcinoma cell lines when compared to normal human dermal fibroblast and transformed 
embryo kidney cell lines9.  Sulphur-based, cysteine-rich, zinc-binding metallothioneins (MTs) have 
shown both increased expression and down regulation in numerous types of types of cancers10.  
Increased copper concentrations and lower iron levels were reported following the analysis of toenail 
clippings from 58 newly diagnosed cutaneous melanoma patients who did not show evidence of 
metastasis compared with 58 control samples11.  In another study, serum trace element levels in healthy 
controls and patients with varying stages of melanoma showed an increase in zinc levels. However, no 
statistical difference in serum copper levels was noted in the melanoma patients12. 
 
Imaging mass spectrometry13 employs matrix-assisted laser desorption/ionisation mass spectrometry 
(MALDI-MS) for the imaging of peptides in tissues by monitoring specific mass-to-charge (m/z) ratios.  
This technique has been applied to glioma biopsies and numerous other diseases14.  In a similar 
manner, elemental bioimaging of tissue sections is possible by employing laser ablation-inductively 
coupled plasma-mass spectrometry (LA-ICP-MS)15. LA-ICP-MS is capable of determining most of the 
elements with a 7 order magnitude linear dynamic range, with detection limits as low as parts per 
trillion. The system utilises a focused laser beam (10 to 200um diameter) directed onto the surface of 
the tissue.  The sample is ablated by an energy transfer from the laser, resulting in a plume of particles 
swept to the ICP by a carrier gas.  The spatial distribution of elements across a tissue sample can be 
determined by collecting mass spectra as the laser traverses the sample in two dimensions. Maps can 
then be constructed of both metals and non-metals essential to physiology. Recently, elemental 
bioimaging has been applied to human glioblastomas16, labelled β-amyloid-bound antibodies in 
Alzheimer’s disease17, implanted tumour cells18 and Cu, Zn and Pt in cis-platin dosed mice19. 
 
The current study demonstrated the potential of elemental bioimaging for detection of metastatic 
melanoma in lymph nodes in human tissues.  Construction of maps presented as single elements or 






Experiments were conducted using a New Wave UP-213 laser ablation unit (Kenelec Technologies, 
Mitcham, Victoria, Australia) hyphenated to a 7500ce ICP-MS (Agilent Technologies, Forrest Hill, 
Victoria, Australia).  A ‘cs’ lens system was fitted to the 7500ce for enhanced sensitivity.  The 
frequency-quintupled Nd:YAG laser produced a laser wavelength of 213 nm.   The LA-ICP-MS system 
was tuned for sensitivity using NIST 612 glass.   
 
Apart from high sensitivity, the instrument was tuned to deliver low oxides. This was done by ablating 
NIST 612 glass and measuring masses 232 and 242 (Th and ThO respectively). Using an RF power 
setting of 1200W and sampling depth of 6mm, ThO/Th ratios were consistently lower than 0.3%. The 
low oxides are attributed, in part, to the laser generated aerosol being essentially dry. In standard 
sample introduction systems, relatively large amounts of solvent (typically water) are passed into the 
plasma, contributing large amounts of oxygen and lowering the effective plasma temperature.  Low 
ThO\Th ratios contributed to generally low matrix derived matrix interferences.  Low sample load from 
the ablated tissue minimised the influence of oxide-based interferences from water in the sample 
matrix.  Measurement of 32S+/34S+ and 56Fe+/57Fe+ ratio in tissue sections confirmed the natural isotopic 
abundance ratios.   
 
Table 1: LA-ICP-MS operation parameters. 
Agilent 7500ce ICP-MS New Wave UP213 Laser Ablation 
Rf Power 1200W Wavelength 213 nm 
Cooling gas flow rate 15 L min-1 Repetition frequency 20 Hz 
Carrier gas flow rate 1.1 L min-1 Laser energy density 0.3 J cm-2 
Sample depth 6.0 mm Spot size 40 µm 
QP Bias -5 V Scan rate 40 µm s-1 
OctP Bias -8 V Line spacing 40 µm 
Scan mode Peak hopping Carrier gas Ar 
Dwell time  0.1 s per m/z   
Measured m/z 13, 31, 32, 34, 56, 57, 63, 66  





A laser spot size of 40 µm and 40 µm s-1 scan was employed to construct the images. Under these 
conditions the recorded counts were at least 10 times above baseline.  Image quality was dependant on 
both the integration time of the MS and the number of elements measured.  An integration time of 0.1 s 
per mass was adequate for the 8 chosen isotopes, 31P, 66Zn, 13C, 32,34S, 56,57Fe and 63Cu. The 0.1 s 
integration time and 40 µm s-1 scan speed resulted in an approximately 4 µm shift from the original 
location of ablation. Scan speed, spot size and integration time were selected in order to generate a true 
image resolution of approximately 40 µm per pixel.  Images were acquired over an approximately 18-
hour period.  The images were constructed as colour maps of relative concentration after normalisation 
to 13C. That is the signal from the isotope of interest was divided by that of 13C to compensate for 
differences in tissue thickness and density, as reported previously15. Relative concentrations were 
suitable as the concentration differences of the isotopes were easily visualised across each lymph node. 
 
LA-ICP-MS data was exported in comma separated variable (CSV) file formats with a separate file 
created for each line of ablation in the x-axis.  A Visual Basic macro was used to both normalise each 
data point to 13C and combine all resultant data into a single ASCII file.  This file was then imported 
into the ITT Visual ENVI 4.2 (Research Systems Inc., Boulder, CO, USA) hyperspectral imaging 
software package, where final images were produced. 
 
Lymph node samples 
 
The study was approved by the institutional review boards of the Royal Prince Alfred Hospital and the 
University of Technology, Sydney. Patients with metastatic melanoma in excised lymph nodes were 
identified from the Sydney Melanoma Unit database. The histological slides and the formalin-fixed, 
paraffin-embedded tissue blocks of the lymph node specimens were retrieved from the archives of the 
Department of Anatomical Pathology at the Royal Prince Alfred Hospital, Sydney, Australia. 
Following review of the original sections, a representative tissue block was selected and section at 5 
µm, then mounted onto slides.  The sections were dewaxed with high purity xylene, ethanol (Sigma 
Aldrich, Castle Hill, NSW, Australia) and 18.2 mΩ water (Sartorius, East Oakliegh, Victoria, 
Australia).  Serial sections were stained with H&E and immunohistochemically for melanoma 
associated antigens S-100 protein, HMB-45 and Melan A.  Histological examination by a 
histopathologist (RAS) confirmed the presence of metastatic melanoma.  Examination of the unstained 
section by the laser’s CCD camera revealed no notable difference in surface structure across the 
sections. 
 
Results and discussion 
 
 Figure 1: Sentinel lymph node partly replaced by metastatic melanoma (upper two thirds of the ovoid-
shaped lymph node). (a) Photograph of slice before elemental imaging, (b) H + E stain, (c) 31P image, 
(d) 31P/34S and (e) 31P/66Zn 
 
Figure 1(a) is a light micrograph of a lymph node containing metastatic melanoma. The image is not 
uniform in colour, with slightly darker pigmentation in the lower half. The presence of metastatic 
melanoma could not be detected by visual inspection. The tissue also appeared to be of uniform density 
when viewed with a light microscope. Figure 1(b) shows an H&E stain of a section cut immediately 
adjacent to the section shown in Figure 1(a) and shows metastatic melanoma involving about two thirds 
of the lymph node. H&E stained sections have been reported as suitable for the detection of melanoma 
micrometastases20. The pale areas (predominantly in the upper two thirds of the ovoid lymph node) 
represent metastatic melanoma.  
 
Figure 1 (c) is a 31P image prior to 13C normalisation. There was variation in the concentration of 
phosphorus that corresponded to the presence of the tumour as determined by the H & E stain. Figure 
1(d) is the same image normalised to 13C.  There was significant improvement in contrast in the 
normalised image, particularly on the left side of the section.  This normalisation process also 
compensated for varying thickness in the tissue slice.  
 
There were no significant variations in concentrations of 32,34S, 56,57Fe, 63Cu and 66Zn when imaged as 
separate isotopes (data not shown). Figure 1 (e) clearly shows an increased 31P+/34S+ ratio in the 
peritumoural lymphoid tissue when compared with the metastatic tumour.  Furthermore, the 31P+/34S+ 
ratio improved contrast between the melanoma and lymphoid cells, when compared with 31P+ images 
alone.  Construction of 31P+/66Zn+ ratios (Figure 1 (f)) shows a slightly different perspective on the 
tumour boundary. The blue regions (relatively lower values) penetrated further into the peritumoural, 
apparently uninvolved, lymphoid tissue (determined from the H & E stain) than in the images of the 31P 
and the 31P+/34S+ ratio.  These results suggest changes in biochemistry of the peritumoural lymphoid 
tissue that likely represents a response to the tumour.   
 
Figure 2 shows a 20-x magnification of the tumour boundary overlayed with the corresponding 31P 
image.  Clear evidence of metastatic melanoma was observed on the H&E stained section (the pale area 
in the upper right portion of the lymph node in Fig. 1.b) confirmed by immunohistochemistry.  The 
boundary between healthy and cancerous cells correlated well with the changing intensities of 31P, 
31P/34S and 31P/66Zn 
 
 
Figure 2:  Overlayed 31P image and photomicrograph of lymph node showing boundary of normal and 
metastatic melanoma cells. 
 
Five further lymph nodes containing metastatic melanoma were imaged in a similar way and are shown 
in Figures 3 and 4. The trends discussed above were confirmed in each of the samples.  The central 
node in Figure 3(a) displayed only a very small melanoma micrometastasis on the H&E stained section 
and elemental images clearly identified the presence of tumour cells.  The heightened contrast between 
metastasis and non-tumourous normal lymphoid tissue in 31P/66Zn images was confirmed as shown in 
Figures 3 and 4.  
 
 
 Figure 3: Five lymph nodes each partly involved by metastatic melanoma.  (a) H + E stain, (b) 31P 
image, (c) 31P/34S and (d) 31P/66Zn 
 
 
 Figure 4: Lymph node partly replaced by metastatic melanoma.  (a) H + E stain (the tumour cells 
represent the pale area involving the upper right portion of the lymph node),  (b) 31P image, (c) 31P/34S 




Elemental bio-imaging was used to identify and map metastatic melanoma within single lymph nodes 
according to relative trace element concentrations. There was an excellent correlation between 
decreased relative phosphorus concentration and the presence of the tumour, which was confirmed by 
comparison with standard histopathology.  Additionally, images of trace element ratios provided 
further visual information about malignancy within the nodes.  With further refinement it may be 
possible to apply this method to very small lymph node samples, such as those obtained by fine needle 
biopsy, to determine whether they contain melanoma metastatses. This could obviate the need for 
surgical excision biopsy and formal histopathology of lymph nodes and other tissues to determine 
whether they contain metastases and potentially may have a role in the diagnosis of primary tumours. 
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